Citreamicin alpha, CAS [[122535-63-1]] Preis auf Anfrage
Artikelnummer:
TGM-TN11142
Hersteller Artikelnummer:
TN11142
Alternativnummer:
TGM-TN11142-10MG,TGM-TN11142-50MG
Hersteller:
TargetMol
Kategorie:
Biochemikalien
Alternative Synonym:
LL-E19085alpha
Citreamicin alpha (LL-E 19085-alpha) is an antibiotic that has been evaluated for its in vitro antibacterial activity against 429 clinical isolates of Gram-positive cocci using the agar dilution method. This study included 313 strains of staphylococci and 116 strains of streptococci. Its in vitro efficacy was compared with ampicillin, amoxicillin, cephalothin, erythromycin, and vancomycin. For staphylococci, Citreamicin alpha demonstrated MIC values ranging from 0.12 to 4.0 µg/ml, and for Streptococcus pyogenes, the MIC values ranged from 0.03 to 0.12 µg/ml. Conversely, enterococci presented relative resistance, requiring 2.0 µg/ml to inhibit 64% of 62 tested strains. The antibiotics in vitro efficacy significantly surpassed that of ampicillin, amoxicillin, cephalothin, and erythromycin, while it was comparable to or slightly less effective than vancomycin.
Molekulargewicht:
669.63
CAS Nummer:
[122535-63-1]
Formel:
C36H31NO12
Target-Kategorie:
Antibacterial|||Antibiotic
TN11142
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten